Log in to save to my catalogue

Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elde...

Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elde...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2138067525

Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly - A meta-analysis

About this item

Full title

Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly - A meta-analysis

Publisher

United States: Public Library of Science

Journal title

PloS one, 2018-11, Vol.13 (11), p.e0207947-e0207947

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Metformin is the first-choice drug for patients with Type 2 diabetes, and this therapy is characterized by being weight neutral. However, in the elderly an additional unintentional weight loss could be considered as an adverse effect of the treatment.
We aimed to perform a meta-analysis of placebo-controlled studies investigating the body weight...

Alternative Titles

Full title

Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly - A meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2138067525

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2138067525

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0207947

How to access this item